Insights Home Insights Featured Content Case Study- Technology Case Study: Lithium-Ion Battery Expert Needed for ITC Investigation The complainants approached WIT to provide an expert with extensive knowledge and experience in the relatively narrow field of lithium-ion battery separators, particularly those that were commercially available and utilized in the industry between 2005 and 2008. Article Q1 Litigation Review: Expert Insights on the Wireless, Automotive, and Gaming Industries To understand where legal disputes may lie in 2024, we asked some of our esteemed experts to offer insights on the trajectory of their industry as technology continues to rapidly evolve. Case Study- Life Sciences Case Study: Experienced Urologist Needed for ANDA IP Infringement Dispute The defendant approached WIT to provide an expert who could help bring their drug to market and invalidate the claims of the plaintiff. This case called for an expert who possessed a deep understanding of renal cell carcinoma (kidney cancer). Let's see how WIT was able to meet the ask. Report 2023 in Review: Analyzing Hatch-Waxman Litigation Trends Our inaugural Hatch-Waxman report, 2023 in Review: Analyzing Hatch-Waxman Litigation Trends, provides a comprehensive look at 2023’s activities and trends in Hatch-Waxman litigation. Blog An Expert’s Look at the Wireless Industry Legal Landscape in 2024 What’s to come in the wireless sector for 2024? We asked WIT wireless expert Dr. Muriel Medard to evaluate the industry with regard to 5G technology, industry innovation, and more. Insights & News All Industries Automotive Biotechnology Financial Technology Gaming Healthcare Technology Pharmaceutical Wireless Communications All Trends 2023 Banking Crisis 5G / 6G COVID-19 Cryptocurrency Drug and Vaccine Development Election Law and Voting Rights Electric Vehicles FDA-Regulated Drugs and Devices Lab-Grown Foods Mobile Gaming Payment Systems Virtual Reality Wearable Devices All Insight Types Archive Article Blog Case Study Case Study- Life Sciences Case Study- Technology Event In the News Other Content Press Release Report Video Search March 22, 2024 — Case Study- Life Sciences Case Study: Experienced Urologist Needed for ANDA IP Infringement Dispute The defendant approached WIT to provide an expert who could help bring their drug to market and invalidate the claims of the plaintiff. This case called for an expert who possessed a deep understanding of renal cell carcinoma (kidney cancer). Let's see how WIT was able to meet the ask. March 20, 2024 — Press Release WIT Legal Releases New Report on 2023 Activities and Trends in Hatch-Waxman Litigation The report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue. October 25, 2023 — Event ACI’s 28th Annual Conference on Drug & Medical Device Litigation WIT Legal will be sponsoring ACI's 28th Annual Conference on Drug & Medical Device Litigation on December 5-6 in NYC. October 2, 2023 — Article Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond. July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies. May 24, 2023 — In the News Will the FTC’s Amgen Suit Ignite Future Pharmaceutical M&A Conflicts? With M&A activity in the life sciences sector heating up, the latest dispute in the space may affect the future of pharmaceutical acquisitions. How will the FTC's recent case against Amgen ignite future M&A conflicts, and where can experts assist in the litigation process? May 17, 2023 — Article Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more. April 4, 2023 — Press Release WIT Legal Expands Life Sciences Practice to Address Increase in Litigation Targeting Pharmaceutical, Biotechnology, and Healthcare Technology Companies The company has a reputation for building diverse teams of leading experts across trending areas of litigation and is committed to affiliating with the most qualified experts in emerging markets. March 21, 2023 — In the News QUICK LOOK: What’s Next for Opioid Litigation? While opioid litigation has already crossed a wide swath of drugmakers, distributors, and dispensers, plaintiffs’ attorneys aren’t done yet and have set their sights on a new crop of defendants. Defense teams should assemble and mobilize experts to inform their legal strategies. February 22, 2023 — Blog Pharmaceutical Industry’s Drug Patent Cliffs Approach, Giving Rise to the Need for Highly Credentialed Experts Several patents from the pharmaceutical industry’s best-selling drugs are set to expire. As a result, competition intensifies with copycat drugs already in the works and counsel strategizing on protecting monetized IP. Load More Loading...
Case Study- Technology Case Study: Lithium-Ion Battery Expert Needed for ITC Investigation The complainants approached WIT to provide an expert with extensive knowledge and experience in the relatively narrow field of lithium-ion battery separators, particularly those that were commercially available and utilized in the industry between 2005 and 2008.
Article Q1 Litigation Review: Expert Insights on the Wireless, Automotive, and Gaming Industries To understand where legal disputes may lie in 2024, we asked some of our esteemed experts to offer insights on the trajectory of their industry as technology continues to rapidly evolve.
Case Study- Life Sciences Case Study: Experienced Urologist Needed for ANDA IP Infringement Dispute The defendant approached WIT to provide an expert who could help bring their drug to market and invalidate the claims of the plaintiff. This case called for an expert who possessed a deep understanding of renal cell carcinoma (kidney cancer). Let's see how WIT was able to meet the ask.
Report 2023 in Review: Analyzing Hatch-Waxman Litigation Trends Our inaugural Hatch-Waxman report, 2023 in Review: Analyzing Hatch-Waxman Litigation Trends, provides a comprehensive look at 2023’s activities and trends in Hatch-Waxman litigation.
Blog An Expert’s Look at the Wireless Industry Legal Landscape in 2024 What’s to come in the wireless sector for 2024? We asked WIT wireless expert Dr. Muriel Medard to evaluate the industry with regard to 5G technology, industry innovation, and more.
March 22, 2024 — Case Study- Life Sciences Case Study: Experienced Urologist Needed for ANDA IP Infringement Dispute The defendant approached WIT to provide an expert who could help bring their drug to market and invalidate the claims of the plaintiff. This case called for an expert who possessed a deep understanding of renal cell carcinoma (kidney cancer). Let's see how WIT was able to meet the ask.
March 20, 2024 — Press Release WIT Legal Releases New Report on 2023 Activities and Trends in Hatch-Waxman Litigation The report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue.
October 25, 2023 — Event ACI’s 28th Annual Conference on Drug & Medical Device Litigation WIT Legal will be sponsoring ACI's 28th Annual Conference on Drug & Medical Device Litigation on December 5-6 in NYC.
October 2, 2023 — Article Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond.
July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies.
May 24, 2023 — In the News Will the FTC’s Amgen Suit Ignite Future Pharmaceutical M&A Conflicts? With M&A activity in the life sciences sector heating up, the latest dispute in the space may affect the future of pharmaceutical acquisitions. How will the FTC's recent case against Amgen ignite future M&A conflicts, and where can experts assist in the litigation process?
May 17, 2023 — Article Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more.
April 4, 2023 — Press Release WIT Legal Expands Life Sciences Practice to Address Increase in Litigation Targeting Pharmaceutical, Biotechnology, and Healthcare Technology Companies The company has a reputation for building diverse teams of leading experts across trending areas of litigation and is committed to affiliating with the most qualified experts in emerging markets.
March 21, 2023 — In the News QUICK LOOK: What’s Next for Opioid Litigation? While opioid litigation has already crossed a wide swath of drugmakers, distributors, and dispensers, plaintiffs’ attorneys aren’t done yet and have set their sights on a new crop of defendants. Defense teams should assemble and mobilize experts to inform their legal strategies.
February 22, 2023 — Blog Pharmaceutical Industry’s Drug Patent Cliffs Approach, Giving Rise to the Need for Highly Credentialed Experts Several patents from the pharmaceutical industry’s best-selling drugs are set to expire. As a result, competition intensifies with copycat drugs already in the works and counsel strategizing on protecting monetized IP.
